Hovione is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations. As a Contract Development and Manufacturing Organization (CDMO) with a fully integrated offering of services for drug substances, drug product intermediates and drug products. The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of services, from API, formulation development and devices. Hovione´s culture is based on innovation, quality and dependability. Hovione was the first Chemical/ Pharmaceutical Company to become a Certified B Corp, is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.

Health Care

Life Sciences

Pharmaceutical

Hovione

Jean-Luc Herbeaux

Cristina Martinho

Filipe Ataíde

Luísa Costa Carvalho

Thomas Leperlier

Nuno Hélder Silva

Marta Mourao

Jaime D.

António Fischer Serôdio

Cláudia Moura

Alexandre Ribeiro

Kai Luo

Rita Clemente

Rui Ferreira

Chris Gomez

Marco Gil

Sofia Lee

Antonio Nunes Almeida

Ilda Ventura

Noe Carreira

Liam Keary

John Mahon

Research and Development Team

Business and Operations Team

Analytical Science Team

Leadership Team

Quality Assurance Team

Engineering Team

Sales and Marketing Team

Information Technology Team

Human Resources and Talent Management Team

Teams at Hovione